DHODH-IN-26
DHODH-IN-26 (compound B2) is a mitochondria-targeting DHODH inhibitor. DHODH-IN-26 shows anticancer activity, triggers the formation of reactive oxygen species (ROS), promots mitochondrial lipid peroxidation, and induces ferroptosis.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Formule: C44H34BrF2N2O3P
- Masse moléculaire:787.63
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
Description
In Vitro
DHODH-IN-26 (compound B2) (0.01-100 μM, 72 h) inhibits cell growth of 4T1, B16F10, U251, GL261, SH-SY5Y, U87, and A375 cells[1].
DHODH-IN-26 (50 and 100 nM) inhibits colony formation in B16F10 and A375 cells[1].
DHODH-IN-26 (50 and 100 nM, 48 h) decreases the expression of PD-L1 in B16F10 and A375 cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:4T1, B16F10, U251, GL261, SH-SY5Y, U87, and A375 cells
-
Concentration:0.01, 0.1, 1, 10 and100 μM
-
Incubation Time:72 h
-
Result:Inhibited cell growth.
-
Cell Line:B16F10 and A375 cells
-
Concentration:50 and 100 nM
-
Incubation Time:48 h
-
Result:Decreased the expression of PD-L1.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:B16F10 xenograft model in C57BL/6 mice[1]
-
Dosage:50 mg/kg
-
Administration:I.p.; for 14 days
-
Result:Reduced tumor volume.
Chemical Information
-
Masse moléculaire 787.63
-
Formule C44H34BrF2N2O3P
-
SMILES
CC1=C(C2=CC(F)=CC=C2N=C1C3=CC=C(C=C3)C4=CC=C(C=C4F)NC(CC[P+](C5=CC=CC=C5)(C6=CC=CC=C6)C7=CC=CC=C7)=O)C(O)=O.[Br-]
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)